Division of Dentistry, University of Manchester, Manchester, United Kingdom.
Melbourne Dental School, University of Melbourne, Carlton, Victoria, Australia.
Infect Control Hosp Epidemiol. 2022 Feb;43(2):191-198. doi: 10.1017/ice.2021.87. Epub 2021 Apr 5.
Our objective was to compare patterns of dental antibiotic prescribing in Australia, England, and North America (United States and British Columbia, Canada).
Population-level analysis of antibiotic prescription.
Outpatient prescribing by dentists in 2017.
Patients receiving an antibiotic dispensed by an outpatient pharmacy.
Prescription-based rates adjusted by population were compared overall and by antibiotic class. Contingency tables assessed differences in the proportion of antibiotic class by country.
In 2017, dentists in the United States had the highest antibiotic prescribing rate per 1,000 population and Australia had the lowest rate. The penicillin class, particularly amoxicillin, was the most frequently prescribed for all countries. The second most common agents prescribed were clindamycin in the United States and British Columbia (Canada) and metronidazole in Australia and England. Broad-spectrum agents, amoxicillin-clavulanic acid, and azithromycin were the highest in Australia and the United States, respectively.
Extreme differences exist in antibiotics prescribed by dentists in Australia, England, the United States, and British Columbia. The United States had twice the antibiotic prescription rate of Australia and the most frequently prescribed antibiotic in the US was clindamycin. Significant opportunities exist for the global dental community to update their prescribing behavior relating to second-line agents for penicillin allergic patients and to contribute to international efforts addressing antibiotic resistance. Patient safety improvements will result from optimizing dental antibiotic prescribing, especially for antibiotics associated with resistance (broad-spectrum agents) or C. difficile (clindamycin). Dental antibiotic stewardship programs are urgently needed worldwide.
我们的目的是比较澳大利亚、英国和北美的牙科抗生素处方模式(美国和加拿大不列颠哥伦比亚省)。
抗生素处方的人群水平分析。
2017 年的牙医门诊处方。
在门诊药房接受抗生素治疗的患者。
通过人口调整的基于处方的比率在总体上和按抗生素类别进行比较。列联表评估了各国之间抗生素类别比例的差异。
2017 年,美国牙医的每千人抗生素处方率最高,而澳大利亚的处方率最低。青霉素类,特别是阿莫西林,是所有国家最常开的抗生素。在美国和不列颠哥伦比亚省(加拿大),第二种最常开的药物是克林霉素,在澳大利亚和英格兰是甲硝唑。在澳大利亚和美国,广谱抗生素阿莫西林-克拉维酸和阿奇霉素的使用率最高。
澳大利亚、英国、美国和不列颠哥伦比亚省的牙医开具的抗生素存在巨大差异。美国的抗生素处方率是澳大利亚的两倍,而美国最常开的抗生素是克林霉素。全球牙科界有很大的机会更新他们对青霉素过敏患者二线药物的处方行为,并为解决抗生素耐药性的国际努力做出贡献。优化牙科抗生素处方将提高患者安全,特别是对与耐药性相关的抗生素(广谱抗生素)或艰难梭菌(克林霉素)。全世界都迫切需要开展牙科抗生素管理项目。